1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Japan Dry Eye Syndrome Market

5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Disease Type

6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Evaporative Dry Eye Syndrome
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aqueous Dry Eye Syndrome
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Dosage Form

8.1 Gels
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Eye Solutions
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Capsules & Tablets
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Drops
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Ointments
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region

10.1 Kanto Region
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Kinki Region
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Central/ Chubu Region
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Kyushu-Okinawa Region
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Tohoku Region
10.5.1 Market Trends
10.5.2 Market Forecast
10.6 Chugoku Region
10.6.1 Market Trends
10.6.2 Market Forecast
10.7 Hokkaido Region
10.7.1 Market Trends
10.7.2 Market Forecast
10.8 Shikoku Region
10.8.1 Market Trends
10.8.2 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis
13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis
15 Policy and Regulatory Landscape

16. Competitive Landscape

16.1. AbbVie GK

16.1.1. Business Overview

16.1.2. Company Snapshot

16.1.3. Products & Services

16.1.4. Financials (As Reported)

16.1.5. Recent Developments

16.1.6. Key Personnel Details

16.1.7. SWOT Analysis

16.2. Novartis Pharma K.K.

16.3. Santen Pharmaceutical Co., Ltd.

16.4. Janssen Pharmaceuticals K.K.

16.5. Senju Pharmaceutical Co., Ltd.

16.6. Taisho Pharmaceutical Co., Ltd

16.7. Otsuka Pharmaceutical Co., Ltd.

16.8. Sun Pharma Japan Limited

16.9. Asahi Kasei Pharma Corporation

16.10. Kyowa Pharmaceutical Industry Co., Ltd.

17. Strategic Recommendations

18. About Us & Disclaimer